StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.78+0.01 (+0.21%)

Close on Nov 17, 2026Market cap $59.88MP/E 12.0Yield 3.87%

Lifevantage price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Lifevantage's price to sales ratio was 0.3× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.2× to 1.3×, with a median of 0.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.0
2025Dec 31, 20250.3×−0.8
2024Dec 31, 20241.1×+0.8
2023Dec 29, 20230.4×+0.1
2022Dec 30, 20220.2×−0.2
2021Dec 31, 20210.4×−0.2
2020Dec 31, 20200.6×−0.4
2019Dec 31, 20191.0×+0.1
2018Dec 31, 20180.9×+0.5
2017Dec 29, 20170.3×−0.2
2016Dec 30, 20160.5×−0.2
2015Dec 31, 20150.7×+0.1
2014Dec 31, 20140.6×−0.3
2013Dec 31, 20130.9×−0.6
2012Dec 31, 20121.6×−1.1
2011Dec 30, 20112.7×–

More Lifevantage figures

See a number that looks wrong?